NCT01201018

Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment

A Single Center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment - A Phase I Study

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 7 (actual)
• Sponsor: Oshadi Drug Administration · Industry
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The study will be non randomized, open label, dose rising study in cancer patients. Cancer treatment is consisting of 2 different drugs: Oshadi D and Oshadi R that will be administered orally. The study will include two sessions: * A single dose period to evaluate acute toxicity of each drug * Consecutive multiple increment dose escalation period of both drugs to determine the long-term safety, and the anticancer activity.

Conditions

• Tumor
• Cancer
• Metastasis

Interventions

Type	Name	Description
DRUG	Oshadi D, Oshadi R	Oral administration

Timeline

• Start date: 2011-01-01
• Primary completion: 2012-05-01
• Completion: 2012-05-01
• First posted: 2010-09-14
• Last updated: 2012-06-21

Locations

1 site across 1 country: Israel